Gocovri (extended-release amantidine)
23-10026601
Phase 2 small_molecule active
Quick answer
Gocovri (extended-release amantidine) for Radiation Encephalopathy is a Phase 2 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Radiation Encephalopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active